• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Azab, H., Elsaid, S., Moustafa, M. (2022). UNEXPLAINED ELEVATED MID-TRIMESTER MATERNAL SERUM ALPHA FETO-PROTEIN AS A PREDICTOR OF EARLY ONSET PRE-ECLAMPSIA.-. ALEXMED ePosters, 4(3), 29-30. doi: 10.21608/alexpo.2022.160326.1462
Hossam Ibrahim Azab; Samir Elsaid; Mohamed Saeed Mohamed Moustafa. "UNEXPLAINED ELEVATED MID-TRIMESTER MATERNAL SERUM ALPHA FETO-PROTEIN AS A PREDICTOR OF EARLY ONSET PRE-ECLAMPSIA.-". ALEXMED ePosters, 4, 3, 2022, 29-30. doi: 10.21608/alexpo.2022.160326.1462
Azab, H., Elsaid, S., Moustafa, M. (2022). 'UNEXPLAINED ELEVATED MID-TRIMESTER MATERNAL SERUM ALPHA FETO-PROTEIN AS A PREDICTOR OF EARLY ONSET PRE-ECLAMPSIA.-', ALEXMED ePosters, 4(3), pp. 29-30. doi: 10.21608/alexpo.2022.160326.1462
Azab, H., Elsaid, S., Moustafa, M. UNEXPLAINED ELEVATED MID-TRIMESTER MATERNAL SERUM ALPHA FETO-PROTEIN AS A PREDICTOR OF EARLY ONSET PRE-ECLAMPSIA.-. ALEXMED ePosters, 2022; 4(3): 29-30. doi: 10.21608/alexpo.2022.160326.1462

UNEXPLAINED ELEVATED MID-TRIMESTER MATERNAL SERUM ALPHA FETO-PROTEIN AS A PREDICTOR OF EARLY ONSET PRE-ECLAMPSIA.-

Article 3, Volume 4, Issue 3, September 2022, Page 29-30  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.160326.1462
View on SCiNiTO View on SCiNiTO
Authors
Hossam Ibrahim Azab1; Samir Elsaid2; Mohamed Saeed Mohamed Moustafa email 1
1Department of Obstetrics and Gynecology, Faculty of Medicine- Alexandria University.
2Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Egypt
Abstract
Alpha-fetoprotein (AFP) which is framed by the fetal yolk sac and the fetal liver is a glycoprotein delivered during pregnancy and crosses the placental boundary; An expanded degree of maternal serum AFP (MSAFP) is related with expanding hazard of pregnancy inconveniences as intrauterine development limitation (IUGR), and toxemia.
Serum AFP fixations decline quickly after birth and during the second year of life. From there on, just follow sums are typically identified in serum. The lower furthest reaches of AFP fixation in typical solid grown-ups, non-pregnant is under 1 IU/mL; as far as possible is around 10 IU/mL.
By 12-fourteenth long stretches of growth, AFP fixation in the fetal blood serum arrives at up to 10 mg/ml. After conveyance, AFP in blood levels diminishes to 0.1 mg/ml and in typical grown-ups, it could be seen as just at extremely low focuses (5-10 ng/dL).
Raised second trimester MSAFP relationship between typical embryos chromosomally and the improvement of pre-eclampsia was first detailed by Gordon in 1978.
13% of ladies with raised MSAFP were noted to foster pre-eclampsia contrasted with 1% of the ladies with ordinary MSAFP.
Keywords
Alpha-fetoprotein (AFP); PRE-ECLAMPSIA; pregnancy
Supplementary Files
download 1462 14.pdf
Statistics
Article View: 112
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.